Nkarta

Nkarta, Inc. is a biotechnology company specializing in the development of engineered natural killer (NK) cell therapies for cancer treatment. They generate revenue through the research, development, and commercialization of these innovative therapies, aiming to harness the body's immune system to target and destroy cancer cells. Founded in 2015, Nkarta has made significant strides in advancing their proprietary platform, which focuses on enhancing the efficacy and safety of NK cell therapies. Their commitment to cutting-edge science and improving patient outcomes positions them as a leader in the burgeoning field of cellular immunotherapy.

Recent Posts by Nkarta

1-5 of 5